Prevention and management of central venous catheter occlusion and thrombosis in children with cancer

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 826-830

  Skinner, Roderick ^a   Koller, Karin ^b   McIntosh, Nan ^c   McCarthy, Anthony ^d   Pizer, Barry ^e  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b UKCCSG Data Centre   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Cancer; Central venous catheter; Children; Occlusion; Thromboembolism; Thrombosis

Indexed keywords

ALTEPLASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; UROKINASE; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; CATHETER OCCLUSION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; ECHOCARDIOGRAPHY; FIBRINOLYSIS; HUMAN; LOW DRUG DOSE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM; THORAX RADIOGRAPHY; THROMBECTOMY; THROMBOEMBOLISM; UNITED KINGDOM;

ADULT; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CHILD; HUMANS; NEOPLASMS; QUESTIONNAIRES; THROMBOEMBOLISM; THROMBOSIS;

EID: 40449121216     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21332     Document Type: Article

References (37)

1. Stockwell M, Adams M, Andrew M, et al. Central venous catheters for out-patient management of malignant disorders. Arch Dis Child 1983;58:633-635.
2. Wiener ES, McGuire P, Stolar CJ, et al. The CCSG prospective study of venous access devices: An anlysis of insertions and causes for removal. J Pediatr Surg 1992;27:155-163.
3. Fratino G, Mazzola C, Buffa P, et al. Mechanical complications related to indwelling central venous catheter in pediatric hematology/oncology patients. Pediatr Hematol Oncol 2001;17:317-324.
4. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133:770-776.
5. Athale UH, Chan AKC. Thrombosis in children with acute lymphoblastic leukemia. Part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res 2003;111:125-131.
6. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr Opin Hematol 2003;10:369-374.
7. Agnelli G, Verso M. Therapy insight: Venous-catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol 2006;3:214-222.
8. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995;13:233-238.
9. Molinari AC, Castagnola E, Mazzola C, et al. Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: A retrospective study of 362 catheters. Support Care Cancer 2001;9:539-544.
10. Glaser DW, Medeiros D, Rollins N, et al. Catheter-related thrombosis in children with cancer. J Pediatr 2001;138:255-259.
11. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/hematological diseases: An observational study of 418 devices. Ann Oncol 2005;16:648-654.
12. Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: Pathophysiology, diagnosis, and management. Hematol Oncol Clin N Am 2005;19:183-202.
13. Monreal M, Alastrue A, Rull M, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996;75:251-253.
14. Balestreri L, De Cicco M, Matovic M, et al. central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: A phebographic study. Eur J Radiol 1995;20:108-111.
15. Wilimas JA, Hudosn M, Rao B, et al. Late vascular occlusion of central lines in pediatric malignancies. Pediatrics 1998;101 e7.
16. Monagle P, Michelson AD, Bovill E, et al. Antithrombotic therapy in children. Chest 2001;119:344S-370S.
17. Klerk CPW, Smorenburg SM, Buller HR. Thrombosis prophylaxis in patient populations with a central venous catheter. Arch Intern Med 2003;163:1913-1921.
18. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990;112:423-428.
19. Andrew M, Marzinotto V, Pencharz P, et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995;126:358-363.
20. Couban S, Goodyear M, Burnell M, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005;23:4063-4069.
21. Randolph AG, Cook DJ, Gonzalez CA, et al. Benefit of heparin in central venous and pulmonary artery catheters. Chest 1998;113:165-171.
22. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. Chest 2004;126:338S-400S.
23. Kaste SC, Gronemeyer SA, Hoffer FA, et al. Pilot study of noninvasive detection of venous occlusions from central venous acces devices in children with acute lymphoblastic leukaemia. Pediatr Radiol 1999;29:570-574.
24. Male C, Chait P, Ginsberg JS, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children. Results of the PARKAA Study. Thromb Haemost 2002;87:593-598.
25. Hurtubise MR, Bottino JC, Lawson M, et al. Restoring patency of occluded central venous catheters. Arch Surg 1980;115:212-213.
26. Stokes DC, Rao BN, Mirro J, Jr., et al. Early detection and simplified management of obstructed Hickman and Broviac catheters. J Pediatr Surg 1989;24:257-262.
27. Timoney JP, Malkin MG, Leone DM, et al. Safe and cost effective use of alteplase for the clearance of occluded central venous access devices. J Clin Oncol 2002;20:1918-1922.
28. Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 2001;139:593-596.
29. Ponec D, Irwin D, Haire WD, et al. Recombinant tissue plasminogen activator (Alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial - The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy Trial. J Vasc Interv Radiol 2001;12:951-955.
30. Deitcher SR, Fesen MR, Kiproff PM, et al. Safety and efficacy of Alteplase for restoring function in occluded central venous catheters: Results of the Cardiovascular Thrombolytic to Open Occluded Lines Trial. J Clin Oncol 2001;20:317-324.
31. Choi M, Massicotte MP, Marzinotto V, et al. The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort study. J Pediatr 2001;139:152-156.
32. Haire WD, Atkinson JB, Stephens L, et al. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blind randomized trial. Thromb Haemost 1994;72:543-547.
33. Richardson MW, Allen GA, Monahan PE. Thrombosis in children: Current perspective and distinct challenges. Thromb Haemost 2002;88:900-911.
34. Savage SA, Young G, Reaman GH. Catheter-directed thrombolysis in a child with acute lymphoblastic leukemia and extensive deep vein thrombosis. Med Pediatr Oncol 2000;34:215-217.
35. Tolar B, Gould JR. The timing and sequence of multiple device-related complications in patients wigh long-term indwelling Groshong catheters. Cancer 1996;78:1308-1312.
36. BCSH Clinical Haematology Task Force. BCSH guidelines on the insertion and management of central venous lines. Br J Haematol 1997;98:1041-1047.
37. Royal College of Nursing IV Therapy Forum. Standards for infusion therapy. 2005.